Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.44 |
| ▸ | ARG1 | P05089 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | BLM | P54132 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16397543 | 1.00 | CYP2D6 (0.44) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL19002903 | 1.00 | CYP2D6 (0.44) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL1260591 | 1.00 | CYP2D6 (0.44) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL16397892 | 1.00 | CYP2D6 (0.44) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL16397787 | 1.00 | CYP2D6 (0.44) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| Hydrochloric Acid SCHEMBL1260628 | 0.98 | CYP2D6 (0.43) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL27363554 | 0.82 | CHRNB2 (0.34) | CYP2D6CYP1A2ALOX15CYP2C19 | |
| SCHEMBL20446020 | 0.80 | ALOX15 (0.32) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL20446021 | 0.80 | ALOX15 (0.32) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 | |
| SCHEMBL20446019 | 0.80 | ALOX15 (0.32) | CYP2D6CYP1A2ALOX15CYP2C19SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12558432-B2 | Biocompatible polymeric drug carriers for delivering active agents | CIS BIOPHARMA AG (CH) | 2026-02-24 | — | — | US | disclosed |
| US-20220409737-A1 | BIOCOMPATIBLE POLYMERIC DRUG CARRIERS FOR DELIVERING ACTIVE AGENTS | CIS BIOPHARMA AG (CH) | 2022-12-29 | — | — | US | disclosed |
| EP-4051320-A1 | BIOCOMPATIBLE POLYMERIC DRUG CARRIERS FOR DELIVERING ACTIVE AGENTS | CIS Pharma AG (CH) | 2022-09-07 | — | — | EP | disclosed |
| CN-114641316-A | Biocompatible polymeric drug carriers for delivery of active agents | CIS制药股份公司 | 2022-06-17 | — | — | CN | disclosed |
| US-11008414-B2 | Polymer materials for contact lens applications | CIS PHARMA AG (CH) | 2021-05-18 | — | — | US | disclosed |
| US-20210128735-A1 | BIOCOMPATIBLE COPOLYMER CONTAINING MULTIPLE ACTIVE AGENT MOLECULES | CIS BIOPHARMA AG (CH) | 2021-05-06 | — | — | US | disclosed |
| WO-2021084087-A1 | BIOCOMPATIBLE POLYMERIC DRUG CARRIERS FOR DELIVERING ACTIVE AGENTS | CIS PHARMA AG (CH) | 2021-05-06 | — | — | WO | disclosed |
| EP-3790590-A1 | BIOCOMPATIBLE COPOLYMER CONTAINING MULTIPLE ACTIVE AGENT MOLECULES | CIS Pharma AG (CH) | 2021-03-17 | — | — | EP | disclosed |
| CN-112088016-A | Biocompatible copolymers containing multiple active agent molecules | 化工研究所有限公司 | 2020-12-15 | — | — | CN | disclosed |
| US-20200283560-A1 | New polymer materials for contact lens applications | CIS PHARMA AG (CH) | 2020-09-10 | — | — | US | disclosed |
| WO-2019215207-A1 | BIOCOMPATIBLE COPOLYMER CONTAINING MULTIPLE ACTIVE AGENT MOLECULES | CIS PHARMA AG (CH) | 2019-11-14 | — | — | WO | disclosed |
| EP-3356433-B1 | NEW POLYMER MATERIALS FOR CONTACT LENS APPLICATIONS | CIS PHARMA AG (CH) | 2019-09-18 | — | — | EP | disclosed |
| EP-3356433-A1 | NEW POLYMER MATERIALS FOR CONTACT LENS APPLICATIONS | CIS Pharma AG (CH) | 2018-08-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12558432-B2 | Biocompatible polymeric drug carriers for delivering active agents | MSR1, CD47, SLC43A1 | CYP2D6 1675/4885CYP1A2 3829/4885ALOX15 2533/4885 |
| US-20220409737-A1 | BIOCOMPATIBLE POLYMERIC DRUG CARRIERS FOR DELIVERING ACTIVE AGENTS | CD47, DNPEP, MSR1 | CYP2D6 2911/4885CYP1A2 3900/4885ALOX15 2682/4885 |
| US-20210128735-A1 | BIOCOMPATIBLE COPOLYMER CONTAINING MULTIPLE ACTIVE AGENT MOLECULES | LNPEP, PAICS, CD47 | CYP2D6 4321/4885CYP1A2 4652/4885ALOX15 3243/4885 |
| US-20200283560-A1 | New polymer materials for contact lens applications | CRYAA, CRYAB, BCAT1 | CYP2D6 4570/4885CYP1A2 4572/4885ALOX15 2629/4885 |
| US-11008414-B2 | Polymer materials for contact lens applications | CRYAA, BCAT1, CRYAB | CYP2D6 4360/4885CYP1A2 4487/4885ALOX15 2722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.